Table 1.
Frequency | Percent | |
---|---|---|
Age | ||
| ||
30–39 | 10 | 11% |
40–49 | 19 | 20% |
50–59 | 23 | 24% |
60–69 | 19 | 20% |
70–79 | 13 | 14% |
80+ | 10 | 11% |
| ||
Total | 94 | |
| ||
Race | ||
| ||
European American | 86 | 91% |
African American | 5 | 5% |
Asian/Pacific Islander | 3 | 3% |
| ||
Total | 94 | |
| ||
Clinical Stage | ||
| ||
1 | 20 | 21% |
2 | 22 | 23% |
3 | 10 | 11% |
4 | 5 | 5% |
| ||
Total (available) | 57 | |
| ||
Her2/Neu | ||
| ||
0+ | 38 | 40.43% |
1+ | 15 | 15.96% |
2+ | 4 | 4.26% |